Oncology
Changing the Paradigm of Cancer Drug Discovery and Development with Plants
Martin Brenner, DVM, Ph.D.; Randy Maddux; Steven King
iBio, Inc.
PAO-02-022-CL-02Mar 12, 2022
Orphan Drug
Trovagene Receives Positive Opinion for Orphan Drug Designation in the European Union for PCM-075, Trovagene's Investigational Cancer Drug
Trovagene
PR-M08-18-NI-032Aug 09, 2018